4-(4-(trifluoromethyl)phenyl)-N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxamide,
GSK429286,
GSK429286A,
864082-47-3,
RHO-15,
GSK 429286,
N-(6-FLUORO-1H-INDAZOL-5-YL)-2-METHYL-6-OXO-4-[4-(TRIFLUOROMETHYL)PHENYL]-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXAMIDE,
N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide,
N-(6-fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide,
C21H16F4N4O2,
N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)-phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide,
OLIIUAHHAZEXEX-UHFFFAOYSA-N,
N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyridine-3-carboxamide,
CHEMBL375312,
GTPL9356,
SCHEMBL2801740,
BDBM14055,
CHEBI:91332,
KS-00001CTY,
dihydropyridone indazole amide 15,
DTXSID70463946,
SYN1071,
BCPP000217,
HMS3244C07,
HMS3244C08,
HMS3244D07,
HMS3265C03,
HMS3265C04,
HMS3265D03,
HMS3265D04,
HMS3654N12,
BCP01975,
EX-A1119,
GSK-429286A,
ABP000955,
GSK 429286 A,
GSK 42986,
MFCD16618404,
RS0087,
s1474,
AKOS024457773,
BCP9000743,
CS-0095,
GSK-429286,
GSK 429286 A;RHO-15,
compound 15 [PMID: 17201405],
NCGC00346096-02,
NCGC00346096-10,
4-[4-(TRIFLUOROMETHYL)PHENYL]-N-(6-FLUORO-1H-INDAZOL-5-YL)-2-METHYL-6-OXO-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXAMIDE,
AK198956,
AS-16226,
BC659977,
HY-11000,
FT-0735355,
GSK 429286A;GSK-429286A,
SW219547-1,
X7521,
J3.573.349C,
W-5645,
J-523140,
BRD-A10523515-001-01-2,
N-(6-Fluoro-1H-indazol-5-yl)-1,4,5,6-tetrahydro-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-3-pyridinecarboxamide,
N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-4,5-dihydro-1H-pyridine-3-carboxamide,
N-(6-Fluoro-1h-ndazol-5-yl)-2-methyl-6-Oxo-4-(4-(trfluoromethyl)phenyl)-1,4,5,6-tetrahydropyrdne-3-carboxamde,
cc-634,
GSK 429286A,
CID11373846,
CID 11373846,